Table TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 [see all tables in this series...]

Part (iii) Percentage distribution of route of administration amongst new clients with stimulants (other than cocaine) as primary drug

Country		Inject	Smoke/inhale	Eat/drink	Sniff	Others	Base (known status)	Status unknown
Bulgaria		0.0	0.0	25.0	75.0	0.0	8	0
Czech Republic		60.6	1.3	2.8	35.4	0.0	472	14
Denmark		0.0	0.0	20.9	79.1	0.0	158	33
Germany		0.8	6.6	54.9	29.8	8.0	2258	2692
Ireland		0.0	1.4	86.5	12.2	0.0	74	2
Greece		16.7	33.3	50.0	0.0	0.0	6	0
Spain	(1)	1.0	5.4	48.0	43.1	2.6	392	50
France		1.7	0.0	85.0	11.7	1.7	60	2
Italy		2.7	35.7	53.6	5.4	2.7	224	0
Cyprus		0.0	0.0	100.0	0.0	0.0	6	0
Latvia		81.9	0.0	14.3	3.8	0.0	105	12
Lithuania		69.2	0.0	30.8	0.0	0.0	13	1
Hungary		9.3	3.1	64.8	22.4	0.5	420	0
Malta		0.0	0.0	100.0	0.0	0.0	15	1
Netherlands	(2)	0.7	2.5	28.2	68.2	0.5	443	55
Austria		0.0	1.9	57.4	40.7	0.0	54	4
Slovakia		31.7	27.8	4.0	33.3	3.2	126	4
Finland		60.3	2.7	15.1	21.9	0.0	73	3
Sweden		30.9	0.6	51.2	16.0	1.2	162	9
United Kingdom	(3)	13.7	2.6	72.5	7.7	3.7	2078	215
Total		12.2	5.2	53.0	25.6	4.0	7147	3097

Notes:

 Only countries where there are clients reported with stimulants as primary drug are shown. 

 (1) Data refer to 2005. 

 (2) Data refer to outpatient treatment centres and low-threshold agencies. 

 (3) Data refer to collection period between 1.4.2005 and 31.3.2006. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2007 — TDI — outpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)